Please select an indication

Adults with newly diagnosed FLT3+ acute myeloid leukemia (AML)

RYDAPT® (midostaurin) capsules is an oral prescription medicine used in combination with certain chemotherapy medicines to treat adults with newly diagnosed acute myeloid leukemia (AML) who have a defect in a gene called FLT3. Your doctor will perform a test to make sure RYDAPT is right for you. RYDAPT should not be used alone to induce remission in people with AML. RYDAPT is not safe when given to children in combination with chemotherapy. It is not known if RYDAPT is effective in children.

Aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL)

RYDAPT is an oral prescription medicine used to treat adults with aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL). RYDAPT is not safe when given to children in combination with chemotherapy. It is not known if RYDAPT is effective in children.